Performance at Month End

Merrill Lynch Greater Europe IT PLC 19 April 2005 MERRILL LYNCH GREATER EUROPE INVESTMENT TRUST plc All information is at 31 March 2005 and unaudited. Performance at month end with net income reinvested One Three Since launch Month Months (20Sep04) Net asset value -1.3% 2.3% 13.9% Share price -0.7% 6.9% 9.0% FTSE World Europe ex UK -0.5% 1.5% 12.5% Sources: Merrill Lynch Investment Managers and Datastream. Net asset value and share price performance are both calculated using the issue price of 100.00p. Share price performance was previously released with reference to the first days closing share price of 94.00p. At month end Net asset value: 113.90p Includes net revenue of 0.15p Share price: 109.00p Discount to NAV: 4.3% Gearing: 3.5% Net yield: N/A Total assets: £194.1m Ordinary shares in issue: 164,841,285 Benchmark Sector Analysis Total Assets (%) Index (%) Country Analysis Total Assets (%) Financials 34.6 30.8 France 26.1 Cyclical Services 9.9 6.1 Germany 14.1 Resources 9.6 9.5 Switzerland 11.8 Non Cyclical Consumer Goods 8.1 15.0 Italy 10.3 Basic Industries 6.0 7.2 Scandinavia 8.1 Utilities 5.8 6.3 Sweden 5.2 Non Cyclical Services 5.7 1.4 Russia 3.1 Technology 5.5 4.8 Belgium 3.0 Telecoms 4.7 8.4 Ireland 2.9 Capital Goods 4.6 5.8 Spain 2.8 Cyclical Consumer Goods 3.4 4.7 Turkey 2.7 Other Investments 2.1 - Netherlands 2.6 Greece 2.1 Israel 2.1 Portugal 1.9 Other Countries 1.2 ----- ----- ----- 100.0 100.0 100.0 ----- ----- ----- Ten Largest Equity Investments Company % of Total Assets Country of Risk UBS 4.0 Switzerland Total 3.8 France Sanofi-Aventis 3.1 France Capitalia 2.9 Italy AXA 2.6 France Societe Generale 2.4 France Carrefour 2.4 France Roche Holdings 2.2 Switzerland Belgacom 2.2 Belgium Deutsche Boerse 2.0 Germany ---- Total 27.6 ---- Commenting on the markets, James Macmillan, representing the Investment Manager noted: The start of 2005 saw a continuation of the strong economic growth momentum that marked late 2004. However, this momentum came under pressure during March due to higher energy prices, a pick up in inflation expectations and a rise in bond yields, driven by fears that higher inflation would bring more aggressive interest rate rises. During March the FTSE World Europe ex UK (net) declined by 0.5% in sterling terms and the MSCI Emerging Europe markets fell 8.3%. The Company's NAV returned -1.3% during the month underperforming the reference benchmark index. Cyclical sectors performed well in March with Commercial Services & Supplies (+3%), Hotels, Restaurants & Leisure (+3%) and Consumer Durable and Apparel (+2%) outperforming the market. In addition some of the defensive sectors also did well, these included Household & Personal Products advancing by 4% and Food Beverages & Tobacco up 2%. Semiconductors (-5%) and Technology Hardware & Equipment (-3%) were poor performers. Materials stocks (-3%) suffered profit taking following a strong recent run. During the period both stock and sector selection had a negative effect on performance. From a portfolio perspective the Company benefited from its sector exposure to Pharmaceuticals, Insurance and Energy. The worst contributing sectors were Utilities, Retailing and Telecoms. The Company's exposure to Emerging Europe, particularly Turkey, had a negative impact on performance, due to investors taking profits given the strong performance of many shares in the region so far this year. During the period the best performing stocks were Italian financials Capitalia (+4%) and Fondiaria (+4%), German sportswear manufacture PUMA (+9%) and French retailer Carrefour (+3%). The main detractors were from a number of Greek and Turkish holdings which included banks, Alpha Bank (-10%) and Emporiki Bank of Greece (-17%), Akbank (-18%) and construction group Enka Insaat (-9%). During March the Company purchased Sanofi-Aventis, Fortum and DNB Nor and made significant additions to Deutsche Boerse and Publicis. These were funded by the sale of ING Group, KBC, ASML and Unilever. The main bias of the portfolio remains towards financials, mainly through banks and insurance and more defensively orientated sectors such as energy, telecoms and pharmaceuticals. The main country exposures are in France, Germany and Switzerland. Our exposure to Emerging Europe decreased, finishing the month at 9.4%. The Company ended the month with a net market exposure of 103.5%. The macroeconomic newsflow was mixed in March. Recent surveys suggest that business confidence has deteriorated in Europe against a backdrop of a strong Euro and high energy prices. However, earnings growth remains robust at close to double-digit levels despite weak nominal revenue trends due to corporate restructuring, both financial and operational. European equity valuations look attractive on both an absolute and relative basis. Our outlook remains positive on the Emerging Europe region, medium term, despite the pull back in March. European stocks have so far been unaffected by the increases in U.S. interest rates, however, there could be more inflation scares during the second quarter and the key issue will be the trend in long bonds. We expect that European short rates will stay low during 2005 as economic activity remains sluggish, across most of the large Eurozone countries. However, if the global economy stays on an expansionary trend, then it is not unreasonable to expect long-term interest rates to increase modestly and this would be reflected in European interest rates. Latest information is available by typing www.mlim.co.uk/its on the internet, 'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV terminal). 19 April 2005 This information is provided by RNS The company news service from the London Stock Exchange
UK 100

Latest directors dealings